PEOPX
Price
$67.54
Change
-$0.54 (-0.79%)
Updated
Jul 13 closing price
Net Assets
2.73B
VSTSX
Price
$354.42
Change
-$2.83 (-0.79%)
Updated
Jul 13 closing price
Net Assets
2.3T
Interact to see
Advertisement

PEOPX vs VSTSX

PEOPX vs VSTSX Comparison Chart in %
View a ticker or compare two or three
VS
PEOPX vs. VSTSX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PEOPX is a Buy and VSTSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSTSX has more cash in the bank: 2.3T vs. PEOPX (2.74B). VSTSX pays higher dividends than PEOPX: VSTSX (1.07) vs PEOPX (0.68). PEOPX was incepted earlier than VSTSX: PEOPX (37 years) vs VSTSX (10 years). PEOPX (0.51) is less costly to investors than VSTSX (0.01). VSTSX is a more actively managed with annual turnover of: 3.00 vs. PEOPX (2.80). PEOPX has a lower initial minimum investment than VSTSX: PEOPX (2500) vs VSTSX (5000000000). VSTSX annual gain was more profitable for investors over the last year : 21.48 vs. PEOPX (11.34). VSTSX return over 5 years is better than : 66.56 vs. PEOPX (12.77).
PEOPXVSTSXPEOPX / VSTSX
Total Expense Ratio0.500.015,000%
Annual Report Gross Expense Ratio0.510.015,100%
Fund Existence37 years10 years-
Gain YTD11.07811.20599%
Front LoadN/AN/A-
Min. Initial Investment250050000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets2.74B2.3T0%
Annual Yield % from dividends0.681.0763%
Returns for 1 year11.3421.4853%
Returns for 3 years34.3067.0651%
Returns for 5 years12.7766.5619%
Returns for 10 years38.88239.5316%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
RHTX19.89N/A
N/A
RH Tactical Outlook ETF
PZT22.53-0.01
-0.04%
Invesco New York AMT-Free Muni Bd ETF
DLNV33.01-0.03
-0.08%
FT Vest U.S. Equity Dl Drctl Buf ETF Nov
DFIV55.32-0.11
-0.20%
Dimensional International Value ETF
HQL19.88-0.40
-1.97%
abrdn Life Sciences Investors